• Quotes
  • Shortcuts
The Executive's Internet
Mon, Oct 25th
icon
GoogleAmazonWikipedia


spacerspacer

 

 BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'Market week'. (Return)

MarketWatch MarketPulseOct 25, 2021
FDA committee to discuss BioNTech/Pfizer's COVID-19 shot in children 5 to 11
A Food and Drug Administration advisory committee is set to meet Tuesday to discuss and then recommend whether the benefits outweigh the risks of BioNTech SE and Pfizer Inc.'s COVID-19 vaccine in children between the ages of 5 and 11 years old. The FDA is not required to follow the advice of the committee but often does. The regulator's decision has come within a week of the advisory committee's recommendation in the past. The BioNTech/Pfizer vaccine is currently authorized for teens between the ages of 12 and 15 years old and fully approved for those individuals 16 years and older. If it receives emergency-use authorization, Comirnaty would be the first COVID-19 shot available in the U.S. for this age group. The FDA said Friday that the vaccine generated an efficacy rate of 90.7% against symptomatic infection in 2,268 elementary school-age children seven days after they got the second shot. The most common side effects occurred after the second dose and included pain at the injection site, fatigue, and headache. There were no serious adverse events associated with the vaccine, according to the FDA. The proposed dose for 5- to 11-year-olds is 10 µg, compared with 30 µg used in those 12 years old and older.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



MarketWatch MarketPulseOct 25, 2021
Coronavirus tally: Global cases of COVID-19 near 244 million; Fauci says kids aged 5 to 11 should start getting shots in early-to-mid November
The global tally for the coronavirus-borne illness climbed above 243.7 million on Monday, while the death toll edged above 4.95 million, according to data aggregated by Johns Hopkins University. The U.S. continues to lead the world with a total of 45.4 million cases and 735,941 deaths. The U.S. is averaging more than 1,500 deaths a day, according to a New York Times tracker, although cases and hospitalizations are declining. Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases and President Joe Biden's chief medical adviser, said he expects children aged 5 to 11 to become eligible for vaccines by early-to-mid November. A review panel to the U.'S. Food and Drug Administration found last week that the benefits of the shots outweigh risks, and an advisory committee will convene Tuesday to discuss the matter. If they vote in favor and the CDC grants final approval by next week, Fauci told ABC's "This Week with George Stephanopoulos" that children could start getting their shots shortly after. India is second by cases after the U.S. at 34.2 million and has suffered 44,712 deaths. Brazil has second highest death toll at 605,644 and 21.7 million cases. In Europe, Russia has the most fatalities at 227,506 deaths, followed by the U.K. at 139,950.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



Google Business NewsOct 25, 2021
Stocks, U.S. Futures Steady; Turkey's Lira Slumps: Markets Wrap - Yahoo Finance
Stocks, U.S. Futures Steady; Turkey's Lira Slumps: Markets Wrap  Yahoo FinanceDow futures rise slightly after the blue-chip average notches third winning week in a row  CNBCHoliday earnings forecasts have been lumps of coal so far, and here come the biggest ones  MarketWatchBig Tech companies report earnings: What to know this week  Yahoo Finance
TRENDING TAGS
TeslaHertz record Buy Stock vehicles
FacebookEarnings documents whistle-blower Frances Haugen
StockBuy Tesla Earnings Market record
EarningsStocks Facebook Stock ahead higher
StocksEarnings Buy tech Week Tesla
HertzTesla buy Stock vehicles EVs
BuyStock Stocks Tesla Hertz Pacific
VaccineCovid COVID-19 Times Boosters Widely
COVIDCOVID-19 Vaccine vaccines Financial shot
RecordTesla Stock Dow hits Hertz

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2021 CEOExpress Company LLC